DOT1L decelerates the development of osteoporosis by inhibiting SRSF1 transcriptional activity via microRNA-181-mediated KAT2B inhibition

CONCLUSION: DOT1L overexpression slowed down bone loss and promoted bone formation via the miR-181/KAT2B/SRSF1 axis, thereby alleviating OP development.PMID:38072145 | DOI:10.1016/j.ygeno.2023.110759
Source: Genomics - Category: Genetics & Stem Cells Authors: Source Type: research